These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prodromal immune manifestations in EMC-M virus induced diabetes: islet bound and circulating antibodies, and changes in lymphocyte subsets. Buschard K; Rygaard J; Lund E; Röpke C Diabetes Res; 1987 Jun; 5(2):67-72. PubMed ID: 2820645 [TBL] [Abstract][Full Text] [Related]
23. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. II. Effect of multiple doses of polyriboinosinic-polyribocytidylic acid on viral pathogenesis. Stringfellow DA; Overall JC; Glasgow LA J Infect Dis; 1974 Nov; 130(5):481-8. PubMed ID: 4371529 [No Abstract] [Full Text] [Related]
24. Antibody response in baboons (Papio cynocephalus anubis) to a commercially available encephalomyocarditis virus vaccine. Huneke RB; Michaels MG; Kaufman CL; Ildstad ST Lab Anim Sci; 1998 Oct; 48(5):526-8. PubMed ID: 10090069 [No Abstract] [Full Text] [Related]
25. Estimation of seroprevalence of encephalomyocarditis in Dutch sow herds using the virus neutralization test. Augustijn M; Elbers AR; Koenen F; Nielen M Tijdschr Diergeneeskd; 2006 Jan; 131(2):40-4. PubMed ID: 16454087 [TBL] [Abstract][Full Text] [Related]
26. Isolation of encephalomyocarditis (EMC) virus strains in India. Paul SD; Pavri KM; D'Lima LV; Rajagopalan PK; Goverdhan MK; Singh KR Indian J Med Res; 1968 Mar; 56(3):264-74. PubMed ID: 4298069 [No Abstract] [Full Text] [Related]
27. Depletion of Mac1-positive macrophages protects DBA/2 mice from encephalomyocarditis virus-induced myocarditis and diabetes. Hirasawa K; Tsutsui S; Takeda M; Mizutani M; Itagaki S; Doi K J Gen Virol; 1996 Apr; 77 ( Pt 4)():737-41. PubMed ID: 8627262 [TBL] [Abstract][Full Text] [Related]
28. Encephalomyocarditis (EMC) virus-induced myocarditis by different virus variants and mouse strains. Hirasawa K; Han JS; Takeda M; Itagaki S; Doi K J Vet Med Sci; 1992 Dec; 54(6):1125-9. PubMed ID: 1335759 [TBL] [Abstract][Full Text] [Related]
29. Interaction between encephalomyocarditis (EMC) virus and polio-virus in cultured cells. Increase in the number of EMC virus-producing cells. Shirman GA; Maslova SV; Gavrilovskaya IN; Agol VI Acta Virol; 1972 Mar; 16(2):175. PubMed ID: 4401077 [No Abstract] [Full Text] [Related]
31. Encephalomyocarditis (EMC) virus infection in PC12 and C6 cells. Su W; Ueno-Yamanouchi A; Nakayama H; Doi K Int J Exp Pathol; 1998 Dec; 79(6):411-6. PubMed ID: 10319021 [TBL] [Abstract][Full Text] [Related]
32. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis. Stringfellow DA; Overall JC; Glasgow LA J Infect Dis; 1974 Nov; 130(5):470-80. PubMed ID: 4371528 [No Abstract] [Full Text] [Related]
33. Distribution and titres of rotavirus antibodies in different age groups. Elias MM J Hyg (Lond); 1977 Dec; 79(3):365-72. PubMed ID: 200676 [TBL] [Abstract][Full Text] [Related]
34. [ENCEPHALOMYOCARDITIS (EMC) VIRUSES. ANTIBODY DETERMINATIONS ON HEALTHY SUBJECTS IN THE HALLE AREA]. KOEHLER W; SCHMIDT RM Z Arztl Fortbild (Jena); 1963 Sep; 57():983-6. PubMed ID: 14091776 [No Abstract] [Full Text] [Related]
35. Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells. Kaptur PE; Thomas DC; Giron DJ Diabetes; 1989 Sep; 38(9):1103-8. PubMed ID: 2475377 [TBL] [Abstract][Full Text] [Related]
36. Role of Hck in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. Choi KS; Jun HS; Kim HN; Park HJ; Eom YW; Noh HL; Kwon H; Kim HM; Yoon JW J Virol; 2001 Feb; 75(4):1949-57. PubMed ID: 11160694 [TBL] [Abstract][Full Text] [Related]
37. Alterations in immunological reactivity in encephalomyocarditis virus-induced murine diabetes. I. Defective primary IgM plaque forming cell responses to sheep erythrocytes: correction by islet cell transplantation. Handwerger BS; Fernandes G; Riehm T; Yoon JW; Sutherland DE; Brown DM Clin Exp Immunol; 1985 Apr; 60(1):145-50. PubMed ID: 2988831 [TBL] [Abstract][Full Text] [Related]
38. The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses. Kraaijeveld CA; Schilham M; Jansen J; Benaissa-Trouw B; Harmsen M; van Houte AJ; Snippe H Clin Exp Immunol; 1984 Jun; 56(3):509-14. PubMed ID: 6086188 [TBL] [Abstract][Full Text] [Related]
39. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera. Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS Virol J; 2016 Mar; 13():44. PubMed ID: 26987753 [TBL] [Abstract][Full Text] [Related]
40. Serosurvey of encephalomyocarditis virus neutralizing antibodies in southern Louisiana and Peruvian Indian populations. JONKERS AH Am J Trop Med Hyg; 1961 Jul; 10():593-8. PubMed ID: 13790625 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]